The short answer is: likely yes, with appropriate medical supervision
Weight loss outcomes vary between individuals
Depression ranges from everyday situational depression to major depressive disorder, characterized by profound hopelessness, helplessness, and biological symptoms such as sleep disorders and anhedonia and can be mimicked by symptoms of cirrhosis like HE and delirium, necessitating careful psychiatric differential diagnoses
PlexusDx compounded oral semaglutide ($289/mo), compounded tirzepatide injection ($289/mo), oral tirzepatide ($349/mo), and combination GLP-Squared formulations all qualify for HSA and FSA reimbursement when prescribed by PlexusDx clinicians
At the 15 mg maintenance dose, participants achieved 22.5% average body weight reduction over 72 weeks
To access, complete the health survey below, and a member of our team will review your case prior to dispatch